Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...

Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...

Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most artificial intelligence (AI) tools rely on dermoscopic images alone, they ...

In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...

Bottom line: A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), ...

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.